Last reviewed · How we verify

NCT05953571

Laparoscopic Assisted Dismembered Pyeloplasty Versus Open Pyeloplasty in (UPJO) With Poorly Function Kidney in Pediatrics

Completed Last updated 20 July 2023
What this trial tests

trial testing Dismembered Pyeloplasty in Uretro-pelvic Junction Obstruction in 65 participants. Completed in 30 June 2023.

Timeline
8 January 2022
Primary endpoint
8 March 2023
30 June 2023

Quick facts

Lead sponsorAl-Azhar University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment65
Start date8 January 2022
Primary completion8 March 2023
Estimated completion30 June 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Al-Azhar University

Who can join

Adults 2 Months to 14, any sex, with Uretro-pelvic Junction Obstruction or Poorly Function Kidney. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The management of kidneys with poor function less than 10% has been the subject of debate for more than a decade. Some authors have recommended nephrectomy while others favor renal salvage (pyeloplasty). the investigators reported their experience of lap assisted pyeloplasty in poorly functioning kidneys in the pediatric age group, concerning on the benefits of a minimally invasive method for repair of UPJO, in comparison with open approach.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Laparoscopic assisted dismembered pyeloplasty versus open pyeloplasty in UPJO with poorly function kidney in pediatrics.
    Daboos M, Lamiri R, Aziza B, Marzougui M, et al · · 2024 · cited 2× · PMID 37751052 · DOI 10.1007/s11255-023-03799-4

Verify or expand the search:

Other Al-Azhar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05953571.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing